Style | Citing Format |
---|---|
MLA | Mahdavi A, et al.. "Effect of Levetiracetam Drug on Antioxidant and Liver Enzymes in Epileptic Patients: Case-Control Study." African Health Sciences, vol. 20, no. 2, 2020, pp. 984-990. |
APA | Mahdavi A, Naeini AA, Najafi M, Maracy M, Ghazvini MA (2020). Effect of Levetiracetam Drug on Antioxidant and Liver Enzymes in Epileptic Patients: Case-Control Study. African Health Sciences, 20(2), 984-990. |
Chicago | Mahdavi A, Naeini AA, Najafi M, Maracy M, Ghazvini MA. "Effect of Levetiracetam Drug on Antioxidant and Liver Enzymes in Epileptic Patients: Case-Control Study." African Health Sciences 20, no. 2 (2020): 984-990. |
Harvard | Mahdavi A et al. (2020) 'Effect of Levetiracetam Drug on Antioxidant and Liver Enzymes in Epileptic Patients: Case-Control Study', African Health Sciences, 20(2), pp. 984-990. |
Vancouver | Mahdavi A, Naeini AA, Najafi M, Maracy M, Ghazvini MA. Effect of Levetiracetam Drug on Antioxidant and Liver Enzymes in Epileptic Patients: Case-Control Study. African Health Sciences. 2020;20(2):984-990. |
BibTex | @article{ author = {Mahdavi A and Naeini AA and Najafi M and Maracy M and Ghazvini MA}, title = {Effect of Levetiracetam Drug on Antioxidant and Liver Enzymes in Epileptic Patients: Case-Control Study}, journal = {African Health Sciences}, volume = {20}, number = {2}, pages = {984-990}, year = {2020} } |
RIS | TY - JOUR AU - Mahdavi A AU - Naeini AA AU - Najafi M AU - Maracy M AU - Ghazvini MA TI - Effect of Levetiracetam Drug on Antioxidant and Liver Enzymes in Epileptic Patients: Case-Control Study JO - African Health Sciences VL - 20 IS - 2 SP - 984 EP - 990 PY - 2020 ER - |